NCT07206979

An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 660 (estimated)
• Sponsor: Radicle Science · Industry
• Sex: All
• Age: 21 Years – 105 Years
• Healthy volunteers: Accepted

Summary

An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health

Detailed description

This is an open label study conducted with adult participants residing in the United States. Eligible participants will (1) agree to consume a hydration product, (2) agree not to take any other hydration or electrolyte supplements for the duration of the trial, (3) be 21 years of age or older, and (4) agree to participate in this study for 2 week and answer assessments. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants over 2 weeks. Participant reports of health indicators will be collected at screening and throughout the active period of study product use. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

Conditions

• Hydration

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Hydration Active Product 1	Participants will use their Hydration Active Product 1 as directed for a period of 1 week.
DIETARY_SUPPLEMENT	Hydration Active Product 2	Participants will use their Hydration Active Product 2 as directed for a period of 1 week.
DIETARY_SUPPLEMENT	Hydration Active Product 3	Participants will use their Hydration Active Product 3 as directed for a period of 1 week.

Timeline

• Start date: 2025-09-30
• Primary completion: 2026-09-30
• Completion: 2026-09-30
• First posted: 2025-10-03
• Last updated: 2025-10-03

Locations

1 site across 1 country: United States